AstraZeneca and GSK, the U.K.’s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
Thank you for reading this post, don't forget to subscribe!UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
108144276 17470722822025 05 12t173618z 940040002 rc2yj8abm3ue rtrmadp 0 usa trump drugpricing.jpeg
